Structural-Based Rational Design of an Antagonist Peptide That Inhibits the Ribosome-Inactivating Activity of Ricin A Chain
Wang Shuntao(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Bing Shen(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Meiru Hu(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Guo Jianwei(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Yingxun Sun(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Weisong Qin(Institute of Basic Medical Sciences of the Chinese Academy of Medical Sciences), Jiannan Feng(Academy of Military Medical Sciences), Yan Li(Beijing Tongren Hospital)
Cited by 5
Related Papers
Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission
|Science China Life Sciences|2020|2.3k
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis
|International Journal of Molecular Sciences|2018|200
Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product
|Journal of Virology|2002|195
Elevated Expression of IL-33 and TSLP in the Airways of Human Asthmatics In Vivo: A Potential Biomarker of Severe Refractory Disease
|The Journal of Immunology|2018|193